150 related articles for article (PubMed ID: 15187889)
21. Chondrosarcoma: biology, genetics, and epigenetics.
Chow WA
F1000Res; 2018; 7():. PubMed ID: 30519452
[TBL] [Abstract][Full Text] [Related]
22. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
de Andrea CE; San-Julian M; Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
[TBL] [Abstract][Full Text] [Related]
23. The TFG-TEC oncoprotein induces transcriptional activation of the human β-enolase gene via chromatin modification of the promoter region.
Kim AY; Lim B; Choi J; Kim J
Mol Carcinog; 2016 Oct; 55(10):1411-23. PubMed ID: 26310886
[TBL] [Abstract][Full Text] [Related]
24. Translocation (9;22)(q22;q12). A recurrent chromosome abnormality in extraskeletal myxoid chondrosarcoma.
Hirabayashi Y; Ishida T; Yoshida MA; Kojima T; Ebihara Y; Machinami R; Ikeuchi T
Cancer Genet Cytogenet; 1995 May; 81(1):33-7. PubMed ID: 7773957
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
Bovée JV; van den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
Lab Invest; 2000 Dec; 80(12):1925-34. PubMed ID: 11140704
[TBL] [Abstract][Full Text] [Related]
26. Update on chondrosarcomas.
Chow WA
Curr Opin Oncol; 2007 Jul; 19(4):371-6. PubMed ID: 17545802
[TBL] [Abstract][Full Text] [Related]
27. Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes.
Bovée JV; Sciot R; Dal Cin P; Debiec-Rychter M; van Zelderen-Bhola SL; Cornelisse CJ; Hogendoorn PC
Diagn Mol Pathol; 2001 Dec; 10(4):228-35. PubMed ID: 11763313
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case.
Kumar R; Rekhi B; Shirazi N; Pais A; Amare P; Gawde D; Jambhekar N
Diagn Cytopathol; 2008 Dec; 36(12):868-75. PubMed ID: 18925568
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma.
Benini S; Cocchi S; Gamberi G; Magagnoli G; Vogel D; Ghinelli C; Righi A; Picci P; Alberghini M; Gambarotti M
J Mol Diagn; 2014 May; 16(3):314-23. PubMed ID: 24508382
[TBL] [Abstract][Full Text] [Related]
30. Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma.
Clark J; Benjamin H; Gill S; Sidhar S; Goodwin G; Crew J; Gusterson BA; Shipley J; Cooper CS
Oncogene; 1996 Jan; 12(2):229-35. PubMed ID: 8570200
[TBL] [Abstract][Full Text] [Related]
31. The TFG-TEC fusion gene created by the t(3;9) translocation in human extraskeletal myxoid chondrosarcomas encodes a more potent transcriptional activator than TEC.
Lim B; Jun HJ; Kim AY; Kim S; Choi J; Kim J
Carcinogenesis; 2012 Aug; 33(8):1450-8. PubMed ID: 22581839
[TBL] [Abstract][Full Text] [Related]
32. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
Broehm CJ; Wu J; Gullapalli RR; Bocklage T
Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical and molecular genetic approaches to soft tissue tumor diagnosis: a primer.
Hibshoosh H; Lattes R
Semin Oncol; 1997 Oct; 24(5):515-25. PubMed ID: 9344317
[TBL] [Abstract][Full Text] [Related]
34. Extraskeletal myxoid chondrosarcoma: a light microscopic, immunohistochemical, ultrastructural and immuno-ultrastructural study indicating neuroendocrine differentiation.
Goh YW; Spagnolo DV; Platten M; Caterina P; Fisher C; Oliveira AM; Nascimento AG
Histopathology; 2001 Nov; 39(5):514-24. PubMed ID: 11737310
[TBL] [Abstract][Full Text] [Related]
35. Dedifferentiated chondrosarcoma with t(9;22)(q34;q11-12).
Tarkkanen M; Wiklund T; Virolainen M; Elomaa I; Knuutila S
Genes Chromosomes Cancer; 1994 Feb; 9(2):136-40. PubMed ID: 7513544
[TBL] [Abstract][Full Text] [Related]
36. Translocations involving chromosomes 2 and 13 in benign and malignant cartilaginous neoplasms.
Bridge JA; Sanger WG; Neff JR
Cancer Genet Cytogenet; 1989 Mar; 38(1):83-8. PubMed ID: 2713817
[TBL] [Abstract][Full Text] [Related]
37. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases.
Okamoto S; Hisaoka M; Ishida T; Imamura T; Kanda H; Shimajiri S; Hashimoto H
Hum Pathol; 2001 Oct; 32(10):1116-24. PubMed ID: 11679947
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal abnormality t(9;22)(q22;q12) in an extraskeletal myxoid chondrosarcoma characterized by fine needle aspiration cytology, electron microscopy, immunohistochemistry and DNA flow cytometry.
Orndal C; Carlén B; Akerman M; Willén H; Mandahl N; Heim S; Rydholm A; Mitelman F
Cytopathology; 1991; 2(5):261-70. PubMed ID: 1782363
[TBL] [Abstract][Full Text] [Related]
39. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
[TBL] [Abstract][Full Text] [Related]
40. Myxoid chondrosarcoma (chordoid sarcoma) of bone: a report of two cases and review of the literature.
Kilpatrick SE; Inwards CY; Fletcher CD; Smith MA; Gitelis S
Cancer; 1997 May; 79(10):1903-10. PubMed ID: 9149016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
